This inventor holds 1 USPTO granted patent. Top assignee: Yung Shin Pharmaceutical Ind. Co., Ltd.. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Fang Chen Lee: Innovator in Pharmaceutical Compounds
Introduction
Fang Chen Lee is a notable inventor based in Taichung, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds. His work has led to the creation of a unique patent that showcases his expertise and creativity.
Latest Patents
Fang Chen Lee holds a patent for 9H-imidazo[1,2-a]purin-9-one compounds. This patent involves fused tri-heterocyclic compounds with a complex formula that includes various functional groups. The compounds are characterized by their potential applications in medicinal chemistry, highlighting Lee's role in advancing pharmaceutical research.
Career Highlights
Lee is associated with Yung Shin Pharmaceutical Industries Co., Ltd., where he applies his knowledge and skills to develop new pharmaceutical products. His dedication to innovation has positioned him as a key figure in the industry, contributing to the advancement of drug development.
Collaborations
Throughout his career, Fang Chen Lee has collaborated with talented individuals such as Fang Yu Lee and Chang An Yang. These partnerships have fostered a creative environment that encourages the exchange of ideas and expertise.
Conclusion
Fang Chen Lee's contributions to the field of pharmaceuticals through his innovative patents and collaborations demonstrate his commitment to advancing medical science. His work continues to inspire future innovations in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile